arrow
T

Takao Deguchi

national center for child health & development - japan
H指数:35
被引数:3,934

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical and molecular characterization of thrombocytosis in transient abnormal myelopoiesis

特发性暂时性骨髓增殖中血小板增多症的临床与分子特征

Leukemia
IF13.4
2026-05-050
OAAI
Outcomes of children with T-cell acute lymphoblastic leukemia treated with the JACLS T-02 protocol

使用JACLS T-02方案治疗的T细胞急性淋巴细胞白血病患儿的结局

2026-02-010
PRE
Successful reduced-intensity cord blood transplantation in infants with familial hemophagocytic lymphohistiocytosis type 2

在患有家族性2型噬血细胞性淋巴组织细胞增多症的婴儿中成功实施减低强度脐带血移植

2026-02-010
PRE
Posttransplant maintenance with blinatumomab for children, adolescents, and young adults with relapsed and refractory B-cell acute lymphoblastic leukemia: results of phase I in SCT-ALL-BLIN21

儿童、青少年和年轻成年复发难治性B细胞急性淋巴细胞白血病患者移植后维持治疗使用博纳吐单抗:SCT-ALL-BLIN21试验I期结果

2026-01-011
OA
Safety and efficacy of arsenic trioxide in intensification therapy for newly diagnosed childhood acute promyelocytic leukemia: results from the JPLSG AML-P13 study

三氧化二砷在强化治疗新诊断儿童急性早幼粒细胞白血病中的安全性与有效性:JPLSG AML-P13研究的结果

2025-09-010
PRE
A prospective study evaluating the safety and pharmacokinetics of ponatinib at a fixed dose in six paediatric patients with philadelphia chromosome-positive leukaemia: JCCG PedPona19 study

一项前瞻性研究,评估固定剂量帕纳替尼在六例费城染色体阳性白血病儿童患者中的安全性和药代动力学:JCCG PedPona19研究

2025-06-090
PRE
Prognostic Factors for T-Cell Acute Lymphoblastic Leukemia in Children and Young Adults: ALL-T11 Study Conducted By Japan Children's Cancer Group and Japan Adult Leukemia Study Group

儿童和年轻成人T细胞急性淋巴细胞白血病的预后因素:日本儿童癌症组和日本成人白血病研究组进行的ALL-T11研究

BLOOD
IF23.1
2024-11-050
PRE
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk

儿童 γ δ t-all的生物学和临床分析将LMO2/STAG2重排确定为极高风险

2024-06-242
PRE
High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia
LEUKEMIA
IF13.4
2023-11-062
OA
Genome-wide assessment of genetic risk loci for childhood acute lymphoblastic leukemia in Japanese patients
2023-10-261
OAAI
Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosedT-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group
2023-06-0113
OAAI
A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1

一种新型Menin-MLL1抑制剂DS-1594a可预防MLL1重排或NPM1突变的急性白血病的进展

2023-02-2513
OAAI
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemia
2022-08-3014
OAAI
Hematopoietic stem cell transplantation for infants with high-risk KMT2A gene-rearranged acute lymphoblastic leukemia
2021-10-1214
OA